Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of intravenous STC314 in sepsis
CTR20233109Phase 2Active
- Sponsor
- ——/ 远大医药（中国）有限公司
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of STC3141 in sepsis, sponsored by ——/ 远大医药（中国）有限公司. Started Nov 2023; status: active.
02
Drugs
STC3141
03
Conditions
sepsis
Beyond the preview
Go deeper on CTR20233109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233109.